Home › Funds › Royce & Associates › ARQT
Royce & Associates position in ARQT
ARCUTIS BIOTHERAPEUTICS INC · Health Care
Latest position (Q2 2025)374.54K sh
Reported value held$5.25M
Portfolio Weight0.05%
First reportedQ1 2025
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2025 | 267.61K | $4.19M | New |
| Q2 2025 | 374.54K | $5.25M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding ARQT
- BlackRock Inc 10.55M sh · $276.50M · Q2 2026
- Vanguard Group 7.25M sh · $210.65M · Q4 2025
- Morgan Stanley 4.45M sh · $116.71M · Q2 2026
- D. E. Shaw & Co 3.95M sh · $103.56M · Q2 2026
- UBS Group AG 3.33M sh · $87.39M · Q2 2026
- Bank of America Corp 2.99M sh · $78.33M · Q2 2026
- Geode Capital Management 2.98M sh · $78.21M · Q2 2026
- Franklin Resources 1.93M sh · $50.63M · Q2 2026
- Goldman Sachs Group 1.67M sh · $43.74M · Q2 2026
- Janus Henderson Group 1.85M sh · $43.68M · Q1 2026
- Citadel Advisors 1.27M sh · $33.26M · Q2 2026
- Baron Funds 1.25M sh · $32.86M · Q2 2026